Shots::stoohthShots: Bavarian signs an exclusive head of terms agreement with AdaptVac, (a joint venture of ExpreS2ion and NextGen Vaccines) to license AdaptVac’s capsid VLP-based SARS-CoV-2 subunit vaccine. A final agreement […]readmore
Tags : Bavarian Nordic
Shots: GSK to receive $335.9M up front, ~$552.6M milestones including $27.9M as a commercial milestone and $177.5M related to inventory, making the total value as $1B. Bavarian Nordic to get […]readmore
1. Incyte Reports Updated Results of Pemigatinib in P-II FIGHT-202 Trial for Patients with Previously Treated Advanced Cholangiocarcinoma Published: Sept 27, 2019 | Tags: Incyte, Reports, Updated, Results, Pemigatinib, P-II, FIGHT-202 […]readmore
Shots: The US FDA has approved Jynneos as the first non-replicating smallpox (in the US) & monkeypox vaccine to prevent smallpox and monkeypox disease in patients aged≥ 18yrs. determined to […]readmore